GlassScriptPhysician profile
Michael A Eslava
NPI 1114016060
$5,771.41
in general payments reported to CMS, 2019-2025
17 companies · $737 in 2025
The $737 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $640 · 2020: $1,047 · 2021: $758 · 2022: $579 · 2023: $939 · 2024: $1,071 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,743 · Gift: $4.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,743.24 |
| Gift | $4.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,096.81 | 2019-2025 | Lens 4k, Microraptor, Evos |
| Djo, LLC | $772.41 | 2019-2024 | Cmf |
| Stryker Corporation | $460.89 | 2023-2025 | Augment Injectable, Inspace, Alphavent |
| Prime Surgical, LLC | $356.79 | 2020-2021 | |
| Amgen INC. | $247.11 | 2019-2022 | |
| Depuy Synthes Sales INC. | $232.85 | 2023-2025 | Flexhd Acellular Hydrated Dermis, Truespan Orthocord |
| Davol INC. | $163.14 | 2024 | Arista Ah Flexitip |
| Acumed LLC | $112.77 | 2021 | |
| Dynasplint Systems INC. | $81.21 | 2020-2025 | Dynasplint |
| Vertex Pharmaceuticals Incorporated | $63.36 | 2025 | |
| Ethicon US, LLC | $58.44 | 2022-2025 | Dermabond |
| Zimmer Biomet Holdings, INC. | $35.02 | 2025 | Tapestry |
| Kerecis Limited | $26.53 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medtronic, INC. | $17.66 | 2024 | Kyphon Express II Kyphopak Tray |
| Endo Pharmaceuticals INC. | $16.27 | 2023 | Xiaflex |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $15.58 | 2025 | Triluron, Hymovis |
| Innovation Technologies INC | $14.57 | 2023 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Eslava listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.